nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—CYP1A2—Estropipate—osteoporosis	0.122	0.53	CbGbCtD
Rizatriptan—CYP1A2—Conjugated Estrogens—osteoporosis	0.0575	0.25	CbGbCtD
Rizatriptan—CYP1A2—Estradiol—osteoporosis	0.0505	0.22	CbGbCtD
Rizatriptan—Melatonin—CYP19A1—osteoporosis	0.00313	0.521	CrCbGaD
Rizatriptan—Melatonin—ESR1—osteoporosis	0.00288	0.479	CrCbGaD
Rizatriptan—Asthenia—Estropipate—osteoporosis	0.000662	0.000905	CcSEcCtD
Rizatriptan—Anorexia—Pamidronate—osteoporosis	0.00066	0.000903	CcSEcCtD
Rizatriptan—Myalgia—Zoledronate—osteoporosis	0.00066	0.000903	CcSEcCtD
Rizatriptan—Chest pain—Zoledronate—osteoporosis	0.00066	0.000903	CcSEcCtD
Rizatriptan—Arthralgia—Zoledronate—osteoporosis	0.00066	0.000903	CcSEcCtD
Rizatriptan—Palpitations—Conjugated Estrogens—osteoporosis	0.00066	0.000902	CcSEcCtD
Rizatriptan—Insomnia—Risedronate—osteoporosis	0.000659	0.000901	CcSEcCtD
Rizatriptan—Anxiety—Zoledronate—osteoporosis	0.000658	0.000899	CcSEcCtD
Rizatriptan—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000656	0.000897	CcSEcCtD
Rizatriptan—Paraesthesia—Risedronate—osteoporosis	0.000654	0.000895	CcSEcCtD
Rizatriptan—Pruritus—Estropipate—osteoporosis	0.000652	0.000892	CcSEcCtD
Rizatriptan—Discomfort—Zoledronate—osteoporosis	0.000652	0.000892	CcSEcCtD
Rizatriptan—Asthenia—Alendronate—osteoporosis	0.000652	0.000891	CcSEcCtD
Rizatriptan—Hypersensitivity—Ibandronate—osteoporosis	0.000651	0.000891	CcSEcCtD
Rizatriptan—Cough—Conjugated Estrogens—osteoporosis	0.000651	0.000891	CcSEcCtD
Rizatriptan—Dyspnoea—Risedronate—osteoporosis	0.00065	0.000888	CcSEcCtD
Rizatriptan—Convulsion—Conjugated Estrogens—osteoporosis	0.000647	0.000884	CcSEcCtD
Rizatriptan—Dry mouth—Zoledronate—osteoporosis	0.000645	0.000883	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000645	0.000882	CcSEcCtD
Rizatriptan—Fatigue—Ethinyl Estradiol—osteoporosis	0.000644	0.000881	CcSEcCtD
Rizatriptan—Pruritus—Alendronate—osteoporosis	0.000642	0.000879	CcSEcCtD
Rizatriptan—Dyspepsia—Risedronate—osteoporosis	0.000641	0.000877	CcSEcCtD
Rizatriptan—Tinnitus—Estradiol—osteoporosis	0.00064	0.000875	CcSEcCtD
Rizatriptan—Constipation—Ethinyl Estradiol—osteoporosis	0.000639	0.000874	CcSEcCtD
Rizatriptan—Confusional state—Zoledronate—osteoporosis	0.000638	0.000872	CcSEcCtD
Rizatriptan—Hypersensitivity—Calcitriol—osteoporosis	0.000638	0.000872	CcSEcCtD
Rizatriptan—Flushing—Estradiol—osteoporosis	0.000637	0.000871	CcSEcCtD
Rizatriptan—Myalgia—Conjugated Estrogens—osteoporosis	0.000636	0.000869	CcSEcCtD
Rizatriptan—Arthralgia—Conjugated Estrogens—osteoporosis	0.000636	0.000869	CcSEcCtD
Rizatriptan—Chest pain—Conjugated Estrogens—osteoporosis	0.000636	0.000869	CcSEcCtD
Rizatriptan—Asthenia—Ibandronate—osteoporosis	0.000634	0.000867	CcSEcCtD
Rizatriptan—Anxiety—Conjugated Estrogens—osteoporosis	0.000633	0.000866	CcSEcCtD
Rizatriptan—Nausea—Etidronic acid—osteoporosis	0.000633	0.000866	CcSEcCtD
Rizatriptan—Oedema—Zoledronate—osteoporosis	0.000633	0.000865	CcSEcCtD
Rizatriptan—Anaphylactic shock—Zoledronate—osteoporosis	0.000633	0.000865	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000631	0.000863	CcSEcCtD
Rizatriptan—Diarrhoea—Estropipate—osteoporosis	0.000631	0.000863	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Risedronate—osteoporosis	0.000629	0.00086	CcSEcCtD
Rizatriptan—Fatigue—Risedronate—osteoporosis	0.000628	0.000859	CcSEcCtD
Rizatriptan—Insomnia—Pamidronate—osteoporosis	0.000626	0.000857	CcSEcCtD
Rizatriptan—Pruritus—Ibandronate—osteoporosis	0.000626	0.000855	CcSEcCtD
Rizatriptan—Constipation—Risedronate—osteoporosis	0.000623	0.000852	CcSEcCtD
Rizatriptan—Pain—Risedronate—osteoporosis	0.000623	0.000852	CcSEcCtD
Rizatriptan—Angiopathy—Estradiol—osteoporosis	0.000623	0.000852	CcSEcCtD
Rizatriptan—Shock—Zoledronate—osteoporosis	0.000622	0.000851	CcSEcCtD
Rizatriptan—Paraesthesia—Pamidronate—osteoporosis	0.000622	0.000851	CcSEcCtD
Rizatriptan—Diarrhoea—Alendronate—osteoporosis	0.000621	0.00085	CcSEcCtD
Rizatriptan—Asthenia—Calcitriol—osteoporosis	0.000621	0.000849	CcSEcCtD
Rizatriptan—Nervous system disorder—Zoledronate—osteoporosis	0.00062	0.000849	CcSEcCtD
Rizatriptan—Dyspnoea—Pamidronate—osteoporosis	0.000618	0.000844	CcSEcCtD
Rizatriptan—Tachycardia—Zoledronate—osteoporosis	0.000617	0.000844	CcSEcCtD
Rizatriptan—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000616	0.000842	CcSEcCtD
Rizatriptan—Chills—Estradiol—osteoporosis	0.000616	0.000842	CcSEcCtD
Rizatriptan—Somnolence—Pamidronate—osteoporosis	0.000616	0.000842	CcSEcCtD
Rizatriptan—Pruritus—Calcitriol—osteoporosis	0.000612	0.000837	CcSEcCtD
Rizatriptan—Hyperhidrosis—Zoledronate—osteoporosis	0.000612	0.000836	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000611	0.000836	CcSEcCtD
Rizatriptan—Diarrhoea—Raloxifene—osteoporosis	0.000611	0.000836	CcSEcCtD
Rizatriptan—Dyspepsia—Pamidronate—osteoporosis	0.00061	0.000834	CcSEcCtD
Rizatriptan—Dizziness—Estropipate—osteoporosis	0.00061	0.000834	CcSEcCtD
Rizatriptan—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000609	0.000833	CcSEcCtD
Rizatriptan—Oedema—Conjugated Estrogens—osteoporosis	0.000609	0.000833	CcSEcCtD
Rizatriptan—Diarrhoea—Ibandronate—osteoporosis	0.000605	0.000827	CcSEcCtD
Rizatriptan—Anorexia—Zoledronate—osteoporosis	0.000603	0.000825	CcSEcCtD
Rizatriptan—Decreased appetite—Pamidronate—osteoporosis	0.000602	0.000823	CcSEcCtD
Rizatriptan—Mental disorder—Estradiol—osteoporosis	0.000601	0.000822	CcSEcCtD
Rizatriptan—Dizziness—Alendronate—osteoporosis	0.000601	0.000821	CcSEcCtD
Rizatriptan—Shock—Conjugated Estrogens—osteoporosis	0.000599	0.00082	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000598	0.000818	CcSEcCtD
Rizatriptan—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000597	0.000817	CcSEcCtD
Rizatriptan—Erythema—Estradiol—osteoporosis	0.000597	0.000817	CcSEcCtD
Rizatriptan—Fatigue—Pamidronate—osteoporosis	0.000597	0.000817	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Risedronate—osteoporosis	0.000596	0.000815	CcSEcCtD
Rizatriptan—Tachycardia—Conjugated Estrogens—osteoporosis	0.000595	0.000813	CcSEcCtD
Rizatriptan—Urticaria—Ethinyl Estradiol—osteoporosis	0.000594	0.000812	CcSEcCtD
Rizatriptan—Constipation—Pamidronate—osteoporosis	0.000592	0.00081	CcSEcCtD
Rizatriptan—Pain—Pamidronate—osteoporosis	0.000592	0.00081	CcSEcCtD
Rizatriptan—Diarrhoea—Calcitriol—osteoporosis	0.000592	0.00081	CcSEcCtD
Rizatriptan—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000591	0.000808	CcSEcCtD
Rizatriptan—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000591	0.000808	CcSEcCtD
Rizatriptan—Dizziness—Raloxifene—osteoporosis	0.000591	0.000808	CcSEcCtD
Rizatriptan—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000589	0.000805	CcSEcCtD
Rizatriptan—Flatulence—Estradiol—osteoporosis	0.000589	0.000805	CcSEcCtD
Rizatriptan—Tension—Estradiol—osteoporosis	0.000586	0.000802	CcSEcCtD
Rizatriptan—Vomiting—Estropipate—osteoporosis	0.000586	0.000802	CcSEcCtD
Rizatriptan—Dysgeusia—Estradiol—osteoporosis	0.000585	0.0008	CcSEcCtD
Rizatriptan—Dizziness—Ibandronate—osteoporosis	0.000585	0.0008	CcSEcCtD
Rizatriptan—Rash—Estropipate—osteoporosis	0.000581	0.000795	CcSEcCtD
Rizatriptan—Dermatitis—Estropipate—osteoporosis	0.000581	0.000794	CcSEcCtD
Rizatriptan—Anorexia—Conjugated Estrogens—osteoporosis	0.000581	0.000794	CcSEcCtD
Rizatriptan—Nervousness—Estradiol—osteoporosis	0.00058	0.000794	CcSEcCtD
Rizatriptan—Urticaria—Risedronate—osteoporosis	0.000579	0.000792	CcSEcCtD
Rizatriptan—Headache—Estropipate—osteoporosis	0.000578	0.00079	CcSEcCtD
Rizatriptan—Vomiting—Alendronate—osteoporosis	0.000577	0.00079	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000576	0.000788	CcSEcCtD
Rizatriptan—Abdominal pain—Risedronate—osteoporosis	0.000576	0.000788	CcSEcCtD
Rizatriptan—Body temperature increased—Risedronate—osteoporosis	0.000576	0.000788	CcSEcCtD
Rizatriptan—Muscle spasms—Estradiol—osteoporosis	0.000574	0.000785	CcSEcCtD
Rizatriptan—Rash—Alendronate—osteoporosis	0.000573	0.000783	CcSEcCtD
Rizatriptan—Insomnia—Zoledronate—osteoporosis	0.000572	0.000783	CcSEcCtD
Rizatriptan—Dermatitis—Alendronate—osteoporosis	0.000572	0.000782	CcSEcCtD
Rizatriptan—Feeling abnormal—Pamidronate—osteoporosis	0.000571	0.000781	CcSEcCtD
Rizatriptan—Headache—Alendronate—osteoporosis	0.000569	0.000778	CcSEcCtD
Rizatriptan—Paraesthesia—Zoledronate—osteoporosis	0.000568	0.000777	CcSEcCtD
Rizatriptan—Vomiting—Raloxifene—osteoporosis	0.000568	0.000777	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Pamidronate—osteoporosis	0.000566	0.000775	CcSEcCtD
Rizatriptan—Dyspnoea—Zoledronate—osteoporosis	0.000564	0.000771	CcSEcCtD
Rizatriptan—Rash—Raloxifene—osteoporosis	0.000563	0.00077	CcSEcCtD
Rizatriptan—Dermatitis—Raloxifene—osteoporosis	0.000563	0.000769	CcSEcCtD
Rizatriptan—Somnolence—Zoledronate—osteoporosis	0.000562	0.000769	CcSEcCtD
Rizatriptan—Vomiting—Ibandronate—osteoporosis	0.000562	0.000769	CcSEcCtD
Rizatriptan—Tremor—Estradiol—osteoporosis	0.00056	0.000765	CcSEcCtD
Rizatriptan—Headache—Raloxifene—osteoporosis	0.000559	0.000765	CcSEcCtD
Rizatriptan—Rash—Ibandronate—osteoporosis	0.000557	0.000762	CcSEcCtD
Rizatriptan—Dermatitis—Ibandronate—osteoporosis	0.000557	0.000762	CcSEcCtD
Rizatriptan—Dyspepsia—Zoledronate—osteoporosis	0.000557	0.000762	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000555	0.000759	CcSEcCtD
Rizatriptan—Headache—Ibandronate—osteoporosis	0.000554	0.000757	CcSEcCtD
Rizatriptan—Insomnia—Conjugated Estrogens—osteoporosis	0.000551	0.000754	CcSEcCtD
Rizatriptan—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000551	0.000753	CcSEcCtD
Rizatriptan—Vomiting—Calcitriol—osteoporosis	0.00055	0.000753	CcSEcCtD
Rizatriptan—Decreased appetite—Zoledronate—osteoporosis	0.00055	0.000752	CcSEcCtD
Rizatriptan—Agitation—Estradiol—osteoporosis	0.000549	0.000751	CcSEcCtD
Rizatriptan—Nausea—Estropipate—osteoporosis	0.000548	0.000749	CcSEcCtD
Rizatriptan—Abdominal pain—Pamidronate—osteoporosis	0.000548	0.000749	CcSEcCtD
Rizatriptan—Body temperature increased—Pamidronate—osteoporosis	0.000548	0.000749	CcSEcCtD
Rizatriptan—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000547	0.000748	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000546	0.000747	CcSEcCtD
Rizatriptan—Angioedema—Estradiol—osteoporosis	0.000546	0.000747	CcSEcCtD
Rizatriptan—Rash—Calcitriol—osteoporosis	0.000546	0.000746	CcSEcCtD
Rizatriptan—Fatigue—Zoledronate—osteoporosis	0.000545	0.000746	CcSEcCtD
Rizatriptan—Dermatitis—Calcitriol—osteoporosis	0.000545	0.000746	CcSEcCtD
Rizatriptan—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000543	0.000743	CcSEcCtD
Rizatriptan—Headache—Calcitriol—osteoporosis	0.000542	0.000741	CcSEcCtD
Rizatriptan—Somnolence—Conjugated Estrogens—osteoporosis	0.000542	0.000741	CcSEcCtD
Rizatriptan—Pain—Zoledronate—osteoporosis	0.000541	0.00074	CcSEcCtD
Rizatriptan—Constipation—Zoledronate—osteoporosis	0.000541	0.00074	CcSEcCtD
Rizatriptan—Nausea—Alendronate—osteoporosis	0.000539	0.000738	CcSEcCtD
Rizatriptan—Hypersensitivity—Risedronate—osteoporosis	0.000537	0.000734	CcSEcCtD
Rizatriptan—Vertigo—Estradiol—osteoporosis	0.000537	0.000734	CcSEcCtD
Rizatriptan—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000536	0.000733	CcSEcCtD
Rizatriptan—Asthenia—Ethinyl Estradiol—osteoporosis	0.000536	0.000733	CcSEcCtD
Rizatriptan—Syncope—Estradiol—osteoporosis	0.000536	0.000733	CcSEcCtD
Rizatriptan—Nausea—Raloxifene—osteoporosis	0.00053	0.000725	CcSEcCtD
Rizatriptan—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00053	0.000724	CcSEcCtD
Rizatriptan—Pruritus—Ethinyl Estradiol—osteoporosis	0.000529	0.000723	CcSEcCtD
Rizatriptan—Palpitations—Estradiol—osteoporosis	0.000528	0.000722	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000526	0.000719	CcSEcCtD
Rizatriptan—Fatigue—Conjugated Estrogens—osteoporosis	0.000525	0.000718	CcSEcCtD
Rizatriptan—Nausea—Ibandronate—osteoporosis	0.000525	0.000718	CcSEcCtD
Rizatriptan—Loss of consciousness—Estradiol—osteoporosis	0.000525	0.000718	CcSEcCtD
Rizatriptan—Asthenia—Risedronate—osteoporosis	0.000523	0.000715	CcSEcCtD
Rizatriptan—Feeling abnormal—Zoledronate—osteoporosis	0.000521	0.000713	CcSEcCtD
Rizatriptan—Cough—Estradiol—osteoporosis	0.000521	0.000713	CcSEcCtD
Rizatriptan—Constipation—Conjugated Estrogens—osteoporosis	0.000521	0.000712	CcSEcCtD
Rizatriptan—Pain—Conjugated Estrogens—osteoporosis	0.000521	0.000712	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Zoledronate—osteoporosis	0.000517	0.000708	CcSEcCtD
Rizatriptan—Hypertension—Estradiol—osteoporosis	0.000516	0.000705	CcSEcCtD
Rizatriptan—Pruritus—Risedronate—osteoporosis	0.000516	0.000705	CcSEcCtD
Rizatriptan—Nausea—Calcitriol—osteoporosis	0.000514	0.000703	CcSEcCtD
Rizatriptan—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000511	0.000699	CcSEcCtD
Rizatriptan—Hypersensitivity—Pamidronate—osteoporosis	0.00051	0.000698	CcSEcCtD
Rizatriptan—Arthralgia—Estradiol—osteoporosis	0.000509	0.000696	CcSEcCtD
Rizatriptan—Myalgia—Estradiol—osteoporosis	0.000509	0.000696	CcSEcCtD
Rizatriptan—Chest pain—Estradiol—osteoporosis	0.000509	0.000696	CcSEcCtD
Rizatriptan—Anxiety—Estradiol—osteoporosis	0.000507	0.000693	CcSEcCtD
Rizatriptan—Urticaria—Zoledronate—osteoporosis	0.000503	0.000687	CcSEcCtD
Rizatriptan—Discomfort—Estradiol—osteoporosis	0.000503	0.000687	CcSEcCtD
Rizatriptan—Abdominal pain—Zoledronate—osteoporosis	0.0005	0.000684	CcSEcCtD
Rizatriptan—Body temperature increased—Zoledronate—osteoporosis	0.0005	0.000684	CcSEcCtD
Rizatriptan—Diarrhoea—Risedronate—osteoporosis	0.000499	0.000682	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000498	0.000681	CcSEcCtD
Rizatriptan—Dry mouth—Estradiol—osteoporosis	0.000497	0.00068	CcSEcCtD
Rizatriptan—Asthenia—Pamidronate—osteoporosis	0.000497	0.00068	CcSEcCtD
Rizatriptan—Dizziness—Ethinyl Estradiol—osteoporosis	0.000494	0.000676	CcSEcCtD
Rizatriptan—Confusional state—Estradiol—osteoporosis	0.000492	0.000672	CcSEcCtD
Rizatriptan—Pruritus—Pamidronate—osteoporosis	0.00049	0.00067	CcSEcCtD
Rizatriptan—Anaphylactic shock—Estradiol—osteoporosis	0.000488	0.000667	CcSEcCtD
Rizatriptan—Oedema—Estradiol—osteoporosis	0.000488	0.000667	CcSEcCtD
Rizatriptan—Urticaria—Conjugated Estrogens—osteoporosis	0.000484	0.000662	CcSEcCtD
Rizatriptan—Dizziness—Risedronate—osteoporosis	0.000482	0.000659	CcSEcCtD
Rizatriptan—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000482	0.000659	CcSEcCtD
Rizatriptan—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000482	0.000659	CcSEcCtD
Rizatriptan—Shock—Estradiol—osteoporosis	0.00048	0.000656	CcSEcCtD
Rizatriptan—Nervous system disorder—Estradiol—osteoporosis	0.000478	0.000654	CcSEcCtD
Rizatriptan—Tachycardia—Estradiol—osteoporosis	0.000476	0.000651	CcSEcCtD
Rizatriptan—Vomiting—Ethinyl Estradiol—osteoporosis	0.000475	0.00065	CcSEcCtD
Rizatriptan—Diarrhoea—Pamidronate—osteoporosis	0.000474	0.000648	CcSEcCtD
Rizatriptan—Hyperhidrosis—Estradiol—osteoporosis	0.000471	0.000645	CcSEcCtD
Rizatriptan—Rash—Ethinyl Estradiol—osteoporosis	0.000471	0.000644	CcSEcCtD
Rizatriptan—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000471	0.000644	CcSEcCtD
Rizatriptan—Headache—Ethinyl Estradiol—osteoporosis	0.000468	0.00064	CcSEcCtD
Rizatriptan—Hypersensitivity—Zoledronate—osteoporosis	0.000466	0.000637	CcSEcCtD
Rizatriptan—Vomiting—Risedronate—osteoporosis	0.000463	0.000634	CcSEcCtD
Rizatriptan—Rash—Risedronate—osteoporosis	0.000459	0.000628	CcSEcCtD
Rizatriptan—Dermatitis—Risedronate—osteoporosis	0.000459	0.000628	CcSEcCtD
Rizatriptan—Dizziness—Pamidronate—osteoporosis	0.000458	0.000626	CcSEcCtD
Rizatriptan—Headache—Risedronate—osteoporosis	0.000456	0.000624	CcSEcCtD
Rizatriptan—Asthenia—Zoledronate—osteoporosis	0.000454	0.000621	CcSEcCtD
Rizatriptan—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000449	0.000614	CcSEcCtD
Rizatriptan—Pruritus—Zoledronate—osteoporosis	0.000448	0.000612	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000444	0.000607	CcSEcCtD
Rizatriptan—Nausea—Ethinyl Estradiol—osteoporosis	0.000444	0.000607	CcSEcCtD
Rizatriptan—Insomnia—Estradiol—osteoporosis	0.000441	0.000603	CcSEcCtD
Rizatriptan—Vomiting—Pamidronate—osteoporosis	0.00044	0.000602	CcSEcCtD
Rizatriptan—Paraesthesia—Estradiol—osteoporosis	0.000438	0.000599	CcSEcCtD
Rizatriptan—Asthenia—Conjugated Estrogens—osteoporosis	0.000437	0.000598	CcSEcCtD
Rizatriptan—Rash—Pamidronate—osteoporosis	0.000437	0.000597	CcSEcCtD
Rizatriptan—Dermatitis—Pamidronate—osteoporosis	0.000436	0.000597	CcSEcCtD
Rizatriptan—Dyspnoea—Estradiol—osteoporosis	0.000435	0.000594	CcSEcCtD
Rizatriptan—Headache—Pamidronate—osteoporosis	0.000434	0.000593	CcSEcCtD
Rizatriptan—Somnolence—Estradiol—osteoporosis	0.000433	0.000593	CcSEcCtD
Rizatriptan—Diarrhoea—Zoledronate—osteoporosis	0.000433	0.000592	CcSEcCtD
Rizatriptan—Nausea—Risedronate—osteoporosis	0.000433	0.000592	CcSEcCtD
Rizatriptan—Pruritus—Conjugated Estrogens—osteoporosis	0.000431	0.000589	CcSEcCtD
Rizatriptan—Dyspepsia—Estradiol—osteoporosis	0.000429	0.000587	CcSEcCtD
Rizatriptan—Decreased appetite—Estradiol—osteoporosis	0.000424	0.00058	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Estradiol—osteoporosis	0.000421	0.000576	CcSEcCtD
Rizatriptan—Fatigue—Estradiol—osteoporosis	0.00042	0.000575	CcSEcCtD
Rizatriptan—Dizziness—Zoledronate—osteoporosis	0.000418	0.000572	CcSEcCtD
Rizatriptan—Pain—Estradiol—osteoporosis	0.000417	0.00057	CcSEcCtD
Rizatriptan—Constipation—Estradiol—osteoporosis	0.000417	0.00057	CcSEcCtD
Rizatriptan—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000417	0.00057	CcSEcCtD
Rizatriptan—Nausea—Pamidronate—osteoporosis	0.000411	0.000563	CcSEcCtD
Rizatriptan—Dizziness—Conjugated Estrogens—osteoporosis	0.000403	0.000551	CcSEcCtD
Rizatriptan—Vomiting—Zoledronate—osteoporosis	0.000402	0.00055	CcSEcCtD
Rizatriptan—Feeling abnormal—Estradiol—osteoporosis	0.000402	0.000549	CcSEcCtD
Rizatriptan—Rash—Zoledronate—osteoporosis	0.000399	0.000546	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Estradiol—osteoporosis	0.000399	0.000545	CcSEcCtD
Rizatriptan—Dermatitis—Zoledronate—osteoporosis	0.000399	0.000545	CcSEcCtD
Rizatriptan—Headache—Zoledronate—osteoporosis	0.000396	0.000542	CcSEcCtD
Rizatriptan—Vomiting—Conjugated Estrogens—osteoporosis	0.000387	0.00053	CcSEcCtD
Rizatriptan—Urticaria—Estradiol—osteoporosis	0.000387	0.00053	CcSEcCtD
Rizatriptan—Abdominal pain—Estradiol—osteoporosis	0.000385	0.000527	CcSEcCtD
Rizatriptan—Body temperature increased—Estradiol—osteoporosis	0.000385	0.000527	CcSEcCtD
Rizatriptan—Rash—Conjugated Estrogens—osteoporosis	0.000384	0.000525	CcSEcCtD
Rizatriptan—Dermatitis—Conjugated Estrogens—osteoporosis	0.000384	0.000525	CcSEcCtD
Rizatriptan—Headache—Conjugated Estrogens—osteoporosis	0.000382	0.000522	CcSEcCtD
Rizatriptan—Nausea—Zoledronate—osteoporosis	0.000376	0.000514	CcSEcCtD
Rizatriptan—Nausea—Conjugated Estrogens—osteoporosis	0.000362	0.000495	CcSEcCtD
Rizatriptan—Hypersensitivity—Estradiol—osteoporosis	0.000359	0.000491	CcSEcCtD
Rizatriptan—Asthenia—Estradiol—osteoporosis	0.00035	0.000478	CcSEcCtD
Rizatriptan—Pruritus—Estradiol—osteoporosis	0.000345	0.000472	CcSEcCtD
Rizatriptan—Diarrhoea—Estradiol—osteoporosis	0.000334	0.000456	CcSEcCtD
Rizatriptan—Dizziness—Estradiol—osteoporosis	0.000322	0.000441	CcSEcCtD
Rizatriptan—Vomiting—Estradiol—osteoporosis	0.00031	0.000424	CcSEcCtD
Rizatriptan—Rash—Estradiol—osteoporosis	0.000307	0.00042	CcSEcCtD
Rizatriptan—Dermatitis—Estradiol—osteoporosis	0.000307	0.00042	CcSEcCtD
Rizatriptan—Headache—Estradiol—osteoporosis	0.000305	0.000418	CcSEcCtD
Rizatriptan—Nausea—Estradiol—osteoporosis	0.00029	0.000396	CcSEcCtD
Rizatriptan—HTR1F—Signaling Pathways—TLN1—osteoporosis	8.37e-05	0.00253	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PTH—osteoporosis	8.37e-05	0.00253	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTH1R—osteoporosis	8.37e-05	0.00253	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CALCR—osteoporosis	8.37e-05	0.00253	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	8.27e-05	0.0025	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	8.21e-05	0.00248	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PTH—osteoporosis	8.19e-05	0.00248	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CNR2—osteoporosis	8.16e-05	0.00246	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CALCA—osteoporosis	8.06e-05	0.00243	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CNR2—osteoporosis	7.99e-05	0.00241	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	7.79e-05	0.00235	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PTH—osteoporosis	7.6e-05	0.0023	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PTH—osteoporosis	7.44e-05	0.00225	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	7.42e-05	0.00224	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CNR2—osteoporosis	7.41e-05	0.00224	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—OXCT1—osteoporosis	7.31e-05	0.00221	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CA2—osteoporosis	7.31e-05	0.00221	CbGpPWpGaD
Rizatriptan—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.3e-05	0.00221	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	7.27e-05	0.0022	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CNR2—osteoporosis	7.25e-05	0.00219	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—P4HB—osteoporosis	7.22e-05	0.00218	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—osteoporosis	7.17e-05	0.00217	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—MGLL—osteoporosis	7.12e-05	0.00215	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SOST—osteoporosis	7.05e-05	0.00213	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PTH—osteoporosis	7.02e-05	0.00212	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—POMC—osteoporosis	6.96e-05	0.0021	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—WNT1—osteoporosis	6.96e-05	0.0021	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PTHLH—osteoporosis	6.93e-05	0.0021	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—RAP1A—osteoporosis	6.9e-05	0.00208	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CNR2—osteoporosis	6.84e-05	0.00207	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—WNT1—osteoporosis	6.82e-05	0.00206	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—ADCY5—osteoporosis	6.79e-05	0.00205	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PTHLH—osteoporosis	6.79e-05	0.00205	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MGLL—osteoporosis	6.79e-05	0.00205	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NFATC1—osteoporosis	6.73e-05	0.00203	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—DKK1—osteoporosis	6.68e-05	0.00202	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MGLL—osteoporosis	6.65e-05	0.00201	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LRP5—osteoporosis	6.63e-05	0.002	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—LRP5—osteoporosis	6.49e-05	0.00196	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	6.45e-05	0.00195	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	6.44e-05	0.00195	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—WNT1—osteoporosis	6.43e-05	0.00194	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	6.42e-05	0.00194	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTH1R—osteoporosis	6.37e-05	0.00193	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CALCR—osteoporosis	6.37e-05	0.00193	CbGpPWpGaD
Rizatriptan—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	6.36e-05	0.00192	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LRP6—osteoporosis	6.34e-05	0.00191	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PTHLH—osteoporosis	6.3e-05	0.0019	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—FGA—osteoporosis	6.26e-05	0.00189	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PTH—osteoporosis	6.24e-05	0.00189	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—LRP6—osteoporosis	6.21e-05	0.00187	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—ADCY5—osteoporosis	6.17e-05	0.00186	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PTHLH—osteoporosis	6.17e-05	0.00186	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—TNF—osteoporosis	6.12e-05	0.00185	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CALCA—osteoporosis	6.11e-05	0.00184	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CNR2—osteoporosis	6.08e-05	0.00184	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—IDH2—osteoporosis	6.06e-05	0.00183	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.05e-05	0.00183	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	6e-05	0.00181	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	6e-05	0.00181	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CALCA—osteoporosis	5.98e-05	0.00181	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.9e-05	0.00178	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PTHLH—osteoporosis	5.82e-05	0.00176	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—BMP2—osteoporosis	5.82e-05	0.00176	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP27A1—osteoporosis	5.7e-05	0.00172	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—FGB—osteoporosis	5.69e-05	0.00172	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PTH—osteoporosis	5.67e-05	0.00171	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—POMC—osteoporosis	5.65e-05	0.00171	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CALCA—osteoporosis	5.54e-05	0.00167	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ACP5—osteoporosis	5.54e-05	0.00167	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	5.54e-05	0.00167	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—POMC—osteoporosis	5.53e-05	0.00167	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CNR2—osteoporosis	5.52e-05	0.00167	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PSMA5—osteoporosis	5.5e-05	0.00166	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PSMA2—osteoporosis	5.5e-05	0.00166	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CALCA—osteoporosis	5.43e-05	0.00164	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TLN1—osteoporosis	5.35e-05	0.00162	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TLN1—osteoporosis	5.24e-05	0.00158	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—osteoporosis	5.2e-05	0.00157	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—WNT1—osteoporosis	5.19e-05	0.00157	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PTHLH—osteoporosis	5.17e-05	0.00156	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—TPI1—osteoporosis	5.15e-05	0.00156	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CALCA—osteoporosis	5.12e-05	0.00155	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MGLL—osteoporosis	5.06e-05	0.00153	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—POMC—osteoporosis	5e-05	0.00151	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LRP5—osteoporosis	4.94e-05	0.00149	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL6—osteoporosis	4.94e-05	0.00149	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—P4HB—osteoporosis	4.84e-05	0.00146	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GAPDH—osteoporosis	4.75e-05	0.00144	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LRP6—osteoporosis	4.73e-05	0.00143	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.72e-05	0.00143	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PTHLH—osteoporosis	4.7e-05	0.00142	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KL—osteoporosis	4.65e-05	0.0014	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—RAP1A—osteoporosis	4.63e-05	0.0014	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—P4HB—osteoporosis	4.62e-05	0.00139	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CALCA—osteoporosis	4.55e-05	0.00138	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—POMC—osteoporosis	4.54e-05	0.00137	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—P4HB—osteoporosis	4.52e-05	0.00137	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTH—osteoporosis	4.49e-05	0.00136	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL6R—osteoporosis	4.42e-05	0.00134	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RAP1A—osteoporosis	4.41e-05	0.00133	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTH—osteoporosis	4.4e-05	0.00133	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CNR2—osteoporosis	4.38e-05	0.00132	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—ADCY5—osteoporosis	4.34e-05	0.00131	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RAP1A—osteoporosis	4.32e-05	0.00131	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NFATC1—osteoporosis	4.3e-05	0.0013	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CNR2—osteoporosis	4.28e-05	0.00129	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—DKK1—osteoporosis	4.27e-05	0.00129	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—ADCY5—osteoporosis	4.25e-05	0.00128	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—POMC—osteoporosis	4.22e-05	0.00127	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NFATC1—osteoporosis	4.21e-05	0.00127	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—osteoporosis	4.2e-05	0.00127	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—DKK1—osteoporosis	4.18e-05	0.00126	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CALCA—osteoporosis	4.14e-05	0.00125	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—WNT1—osteoporosis	4.11e-05	0.00124	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—WNT1—osteoporosis	4.03e-05	0.00122	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.01e-05	0.00121	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FGA—osteoporosis	4e-05	0.00121	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TLN1—osteoporosis	3.99e-05	0.00121	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—ADCY5—osteoporosis	3.94e-05	0.00119	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FGA—osteoporosis	3.92e-05	0.00118	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—POMC—osteoporosis	3.88e-05	0.00117	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—ADCY5—osteoporosis	3.86e-05	0.00117	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ENO1—osteoporosis	3.74e-05	0.00113	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTHLH—osteoporosis	3.72e-05	0.00112	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—BMP2—osteoporosis	3.72e-05	0.00112	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PSMA2—osteoporosis	3.69e-05	0.00111	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PSMA5—osteoporosis	3.69e-05	0.00111	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—FDPS—osteoporosis	3.66e-05	0.0011	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PKM—osteoporosis	3.66e-05	0.0011	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ADCY5—osteoporosis	3.64e-05	0.0011	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTHLH—osteoporosis	3.64e-05	0.0011	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—BMP2—osteoporosis	3.64e-05	0.0011	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FGB—osteoporosis	3.64e-05	0.0011	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FGB—osteoporosis	3.56e-05	0.00108	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SPP1—osteoporosis	3.52e-05	0.00106	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PSMA2—osteoporosis	3.51e-05	0.00106	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PSMA5—osteoporosis	3.51e-05	0.00106	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PGLS—osteoporosis	3.47e-05	0.00105	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GPD2—osteoporosis	3.47e-05	0.00105	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—P4HB—osteoporosis	3.44e-05	0.00104	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PSMA5—osteoporosis	3.44e-05	0.00104	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PSMA2—osteoporosis	3.44e-05	0.00104	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTH—osteoporosis	3.35e-05	0.00101	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RAP1A—osteoporosis	3.29e-05	0.000994	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CALCA—osteoporosis	3.28e-05	0.000989	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CNR2—osteoporosis	3.26e-05	0.000986	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—ADCY5—osteoporosis	3.24e-05	0.000979	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NFATC1—osteoporosis	3.21e-05	0.00097	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CALCA—osteoporosis	3.21e-05	0.000969	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—POMC—osteoporosis	3.19e-05	0.000965	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IRS2—osteoporosis	3.19e-05	0.000963	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—DKK1—osteoporosis	3.19e-05	0.000962	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PNP—osteoporosis	3.17e-05	0.000958	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ATIC—osteoporosis	3.17e-05	0.000958	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—POMC—osteoporosis	3.13e-05	0.000945	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—LEP—osteoporosis	3.12e-05	0.000942	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—WNT1—osteoporosis	3.07e-05	0.000927	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP19A1—osteoporosis	2.99e-05	0.000904	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGA—osteoporosis	2.98e-05	0.000902	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ESR1—osteoporosis	2.98e-05	0.0009	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KL—osteoporosis	2.97e-05	0.000898	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—ADCY5—osteoporosis	2.94e-05	0.000889	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KL—osteoporosis	2.91e-05	0.00088	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—POMC—osteoporosis	2.9e-05	0.000876	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—POMC—osteoporosis	2.84e-05	0.000858	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6R—osteoporosis	2.83e-05	0.000855	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IRS1—osteoporosis	2.78e-05	0.000841	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTHLH—osteoporosis	2.77e-05	0.000838	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BMP2—osteoporosis	2.77e-05	0.000838	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6R—osteoporosis	2.77e-05	0.000837	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGB—osteoporosis	2.72e-05	0.00082	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—OXCT1—osteoporosis	2.7e-05	0.000815	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CA2—osteoporosis	2.7e-05	0.000815	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—POMC—osteoporosis	2.68e-05	0.00081	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MGLL—osteoporosis	2.63e-05	0.000794	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PSMA5—osteoporosis	2.62e-05	0.000792	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PSMA2—osteoporosis	2.62e-05	0.000792	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6R—osteoporosis	2.61e-05	0.00079	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IGF1—osteoporosis	2.58e-05	0.000779	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.48e-05	0.000749	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ADCY5—osteoporosis	2.44e-05	0.000739	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CALCA—osteoporosis	2.44e-05	0.000738	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GPX1—osteoporosis	2.44e-05	0.000736	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—POMC—osteoporosis	2.38e-05	0.00072	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADCY5—osteoporosis	2.33e-05	0.000704	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADCY5—osteoporosis	2.28e-05	0.000689	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SPP1—osteoporosis	2.25e-05	0.000681	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—MTHFR—osteoporosis	2.25e-05	0.000679	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—IDH2—osteoporosis	2.23e-05	0.000675	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KL—osteoporosis	2.22e-05	0.00067	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SPP1—osteoporosis	2.21e-05	0.000667	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—POMC—osteoporosis	2.16e-05	0.000654	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6R—osteoporosis	2.11e-05	0.000638	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP27A1—osteoporosis	2.1e-05	0.000635	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ACP5—osteoporosis	2.04e-05	0.000617	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IRS2—osteoporosis	2.04e-05	0.000616	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.02e-05	0.00061	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IRS2—osteoporosis	2e-05	0.000603	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LEP—osteoporosis	1.99e-05	0.000603	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL6—osteoporosis	1.97e-05	0.000595	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—LEP—osteoporosis	1.95e-05	0.00059	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ESR1—osteoporosis	1.9e-05	0.000575	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TPI1—osteoporosis	1.9e-05	0.000574	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ESR1—osteoporosis	1.86e-05	0.000563	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—POMC—osteoporosis	1.8e-05	0.000543	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—P4HB—osteoporosis	1.79e-05	0.00054	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IRS1—osteoporosis	1.78e-05	0.000538	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GAPDH—osteoporosis	1.75e-05	0.00053	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.74e-05	0.000526	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.74e-05	0.000525	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—POMC—osteoporosis	1.71e-05	0.000518	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—RAP1A—osteoporosis	1.71e-05	0.000516	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.68e-05	0.000508	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—POMC—osteoporosis	1.68e-05	0.000507	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.67e-05	0.000505	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.65e-05	0.000498	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.64e-05	0.000494	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.61e-05	0.000488	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MYC—osteoporosis	1.55e-05	0.000468	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TGFB1—osteoporosis	1.55e-05	0.000467	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.52e-05	0.000459	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.49e-05	0.00045	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LEP—osteoporosis	1.49e-05	0.000449	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.42e-05	0.000429	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ENO1—osteoporosis	1.38e-05	0.000417	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PSMA2—osteoporosis	1.36e-05	0.000411	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PSMA5—osteoporosis	1.36e-05	0.000411	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.33e-05	0.000401	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—POMC—osteoporosis	1.28e-05	0.000386	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—osteoporosis	1.26e-05	0.000381	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.25e-05	0.000377	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—osteoporosis	1.23e-05	0.000373	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.23e-05	0.000371	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—osteoporosis	1.16e-05	0.000352	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.1e-05	0.000333	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MYC—osteoporosis	9.91e-06	0.000299	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TGFB1—osteoporosis	9.88e-06	0.000299	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MYC—osteoporosis	9.7e-06	0.000293	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TGFB1—osteoporosis	9.68e-06	0.000292	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—osteoporosis	9.4e-06	0.000284	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ADCY5—osteoporosis	9.02e-06	0.000272	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GPX1—osteoporosis	8.99e-06	0.000271	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MTHFR—osteoporosis	8.29e-06	0.000251	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—osteoporosis	7.45e-06	0.000225	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MYC—osteoporosis	7.39e-06	0.000223	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TGFB1—osteoporosis	7.37e-06	0.000223	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—osteoporosis	7.29e-06	0.00022	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—POMC—osteoporosis	6.63e-06	0.0002	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—osteoporosis	5.55e-06	0.000168	CbGpPWpGaD
